POTENZIERUNG DER ERYTHROPOIESIS

A method for modulating the rate of erythropoiesis in human hematopoietic progenitor cells. FRP is found to be an efficacious potentiator of, and inhibin a suppressor of, erythropoietin-induced differentiation. FRP and inhibin are shown to be functional antagonists of each other, and thus represent...

Full description

Saved in:
Bibliographic Details
Main Authors YU, CHENC-PO, JOHN, VAUGHAN, JOAN, SAN DIEGO, CA 92110, US, VALE, WALKER, JR., WYLIE, LA JOLLA, CA 92037, US, RIVIER, EDOUARD, FREDERIC, JEAN, YU, LIN-TSING, ALICE, SAN DIEGO, CA 92037, US
Format Patent
LanguageGerman
Published 01.07.1993
Edition5
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A method for modulating the rate of erythropoiesis in human hematopoietic progenitor cells. FRP is found to be an efficacious potentiator of, and inhibin a suppressor of, erythropoietin-induced differentiation. FRP and inhibin are shown to be functional antagonists of each other, and thus represent an effective means for modulating erythropoiesis in a number of disease states which are directly caused by or associated with an abnormal rate of erythropoiesis.
Bibliography:Application Number: DE19883879685T